INTERNATIONAL CANCER INSTITUTE
ICI_NORVATIS CAPACITY BUILDING EDUCATION PROGRAM FOR SICKLE CELL DISEASE
CSE200: ICI Sickle Cell Disease Education Program
2nd September 2020 to 16th December 2020
PROGRAM DIRECTOR/PRINCIPLE INVESTIGATOR
Prof. Fredrick Chite Asirwa MD
Consultant Physician. Medical Oncologist and Hematologist
Executive Director, International Cancer Institute
P.O. BOX 8088-30100, Eldoret-Kenya
Office: +254 718 473 446 Mobile: +254 700 522 149
Goal and Objective:
The goal of the ICI_Norvatis Capacity Building Education Program for Sickle Cell Disease is to create awareness amongst healthcare professionals across all cadres in a Multidisciplinary team approach geared towards enhancing the standards of care for Sickle Cell Disease (SCD) in East Africa.
The primary target audience for this course comprises the multidisciplinary clinical Sickle Cell care team members including, but not limited to, physicians; fellows; residents; researchers; SCD nurse practitioners and SCD nurses; SCD pharmacists, SCD PharmTechs; SCD clinical officers; physician assistants; Laboratory scientists and technicians, and other allied health care professionals.
At the end of this educational activity (over the 16 weeks duration), participants should be able to:
- Describe the epidemiology, molecular basis, presentation, and natural history of SCD and the variant sickle cell syndromes.
- Describe the techniques for screening and the diagnosis of SCD; correctly interpret electrophoresis and HPLC traces.
- Understand the pathophysiology and clinical manifestations of sickle cell disease; acute pain crises and progressive organ damage.
- Describe the management of specific major acute complications, including acute chest syndrome, painful crisis, stroke, etc.
- Describe the long-term complications od SCD (including orthopaedic, ophthalmic, renal, pulmonary, endocrine, and fertility issues) and their management, in particular the need for comprehensive multidisciplinary care.
- Understand the use of disease-modifying agents in the management of SCD
- Understand gene therapy, stem cell transplant, and novel therapies in SCD treatment.
- Explain the appropriate use of transfusion in SCD.
- Describe the complications, assessment, and treatment of transfusional iron overload
- Demonstrate a working knowledge and practical competency for acute and chronic pain management in patients with sickle cell disease.
- Design a health maintenance program for Pediatrics, Adolescents, and Young Adults with SCD
- Understand the comprehensive Sickle Cell Disease Management guidelines.
Lecture Schedule (16 weeks)
|Sept 2nd 2020||Epidemiology, Molecular basis, Presentation and Natural History of SCD – Dr. Njuguna||ICI|
|Sept 9th 2020||Screening and the Diagnosis of SCD||ICI|
|Sept 16th 2020||Pathophysiology and Clinical Manifestation of SCD||ICI|
|Sept 23rd 2020||Management of Acute Complications of SCD||ICI|
|Sept 30th 2020||Long-term Complications of SCD and Management I||ICI|
|Oct 7th 2020||Long-term Complications of SCD and Management II||ICI|
|Oct 14th 2020||Disease-Modifying Agents in the Management of SCD – Prof. Chite||ICI|
|Oct 21st 2020||Gene therapy, stem cell transplant and novel therapies in SCD treatment||ICI|
|Oct 28th 2020||Transfusion in SCD||ICI|
|Nov 4th 2020||Iron overload management in SCD – Chite||ICI|
|Nov 11th 2020||Acute and Chronic pain management in patients with sickle cell disease||ICI|
|Nov 18th 2020||Health maintenance in SCD||ICI|
|Nov 25th 2020||Pyschosocial Issues in SCD Management||ICI|
|Dec 2nd 2020||Case discussions in SCD management||ICI|
|Dec 9th 2020||Improving SCD Transitions of Care: From Pediatrics to Young Adult||ICI|
|Dec 16th 2020||Comprehensive Sickle Cell Disease Management Guidelines||ICI|
No Reviews found for this course.